Primary Site >> Biliary tract Cancer
Gene >> CD274
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. PMID: 19697355 |
Ref: Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma. PMID: 24673799 Ref: Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy. PMID: 25368235 |
Ref: High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy. PMID: 26235847 |
Ref: PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma. PMID: 26373575 Ref: Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma. PMID: 27012989 Ref: Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma. PMID: 27626174 Ref: Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy. PMID: 27780932 |
Ref: The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma. PMID: 28139862 Ref: PD-L1 expression in extrahepatic cholangiocarcinoma. PMID: 28419539 Ref: PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma. PMID: 28445951 Ref: Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer. PMID: 28470686 Ref: PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions. PMID: 28502094 Ref: Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer. PMID: 28619747 Ref: Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma PMID: 28670887 Ref: PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma. PMID: 28693161 |
Ref: Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma. PMID: 29732001 Ref: Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma. PMID: 29805739 Ref: Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy. PMID: 29882997 Ref: New developments in systemic therapy for advanced biliary tract cancer. PMID: 29893894 Ref: Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis. PMID: 29954840 Ref: Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression. PMID: 30055582 Ref: Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+) T-cell immune responses. PMID: 30323667 Ref: Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. PMID: 30377340 |